A randomized-controlled trial of an intervention to improve antidepressant adherence among latinos with depression

Depression and Anxiety

Volumn 30, Issue 7, 2013, Pages 688-696

  Interian, Alejandro ^a,b   Lewis Fernández, Roberto ^c   Gara, Michael A ^b,d   Escobar, Javier I ^b,e  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d University of Medicine and Dentistry of New Jersey   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

adherence; antidepressants; depression; ethnicity race; minority groups

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COMMUNITY MENTAL HEALTH CENTER; DEPRESSION; DRUG EFFICACY; DSM-IV; DYSTHYMIA; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION;

ADHERENCE; ANTIDEPRESSANTS; DEPRESSION; ETHNICITY/RACE; MINORITY GROUPS;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; COMMUNITY MENTAL HEALTH CENTERS; DEPRESSIVE DISORDER; FEASIBILITY STUDIES; FEMALE; FOCUS GROUPS; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING;

EID: 84879785633     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22052     Document Type: Article

References (41)

1. Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder. Neuropsychopharmacology 2006; 31: 1841-1853.
2. Adli M, Bauer M, Rush AJ,. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry 2006; 59: 1029-1038.
3. Bauer M, Pfennig A, Linden M, Smolka MN, Neu P, Adli M,. Efficacy of an Algorithm-Guided Treatment Compared With Treatment as Usual: A Randomized, Controlled Study of Inpatients With Depression. Journal of Clinical Psychopharmacology 2009; 29: 327-333. doi: 310. 1097/JCP.1090b1013e3181ac4839.
4. Blom MBJ, Jonker K, Dusseldorp E, et al. Combination Treatment for Acute Depression Is Superior Only when Psychotherapy Is Added to Medication. Psychotherapy and Psychosomatics 2007; 76: 289-297.
5. Brown GW, Harris TO, Kendrick T, et al. Antidepressants, social adversity and outcome of depression in general practice. Journal of Affective Disorders 2010; 121: 239-246.
6. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R,. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 2009; 77: 775-787.
7. Akincigil A, Bowblis JR, Levin C, Walkup JT, Jan S, Crystal S,. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Medical Care 2007; 45: 363-369.
8. Hunot VM, Horne R, Leese ML, Churchill RC,. A cohort study of antidepressant adherence in primary care: The influence of antidepressant concerns and treatment preferences. Primary Care Companion Journal of Clinical Psychiatry 2007; 9: 91-99.
9. Warden D, Trivedi M, Wisniewski SR, et al. Predictors of Attrition During Initial (Citalopram) Treatment for Depression: A STAR*D Report. American Journal of Psychiatry 2007; 164: 1189-1197.
10. Olfson M, Marcus SC, Tedeschi M, Wan GJ,. Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry 2006; 163: 101-108.
11. Lanouette NM, Folsom DP, Sciolla A, et al. Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review. Psychiatric Services 2009; 60: 157-174.
12. Sleath B, Rubin RH, Huston SA,. Hispanic ethnicity, physician-patient communication, and antidepressant adherence. Compr Psychiatry 2003; 44: 198-204.
13. Warden D, Rush AJ, Wisniewski SR, et al. What predicts attrition in second step medication treatments for depression?: a STAR*D Report. Int J Neuropsychopharmcol 2009; 12: 459-473.
14. Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET,. Continuity is the main challenge in treating major depressive disorder in psychiatric care. Journal of Clinical Psychiatry 2005; 66: 220-227.
15. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K,. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Archives of General Psychiatry 1998; 55: 1128-1132.
16. Miranda J, Duan N, Sherbourne C, et al. Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial. Health services research 2003; 38: 613-630.
17. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Medical Care 2003; 41: 479-489.
18. Givens JL, Houston TK, Van Voorhees BW, Ford DE, Cooper LA,. Ethnicity and preferences for depression treatment. General Hospital Psychiatry 2007; 29: 182-191.
19. Hettema J, Steele J, Miller W,. Motivational interviewing. Annual Review of Clinical Psychology 2005; 1: 91-111.
20. Kemp R, Hayward P, Applewhaite G, Everitt B, David A,. Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal 1996; 312: 345-349.
21. Miller WR, Rose GS, Miller WR, Rose GS,. Toward a theory of motivational interviewing. American Psychologist 2009; 64: 527-537.
22. Interian A, Martinez I, Iglesias Rios L, Krejci J, Guarnaccia PJ,. Adaptation of a Motivational Interviewing Intervention to Improve Antidepressant Adherence among Latinos. Cultural Diversity & Ethnic Minority Psychology 2010; 16: 215-225.
23. First MB, Spitzer RL, Gibbon M, Williams JBW,. Structured Clinical Interview for DSM-IV Axis I Disorders. New York: Biometric Research Department, New York State Psychiatric Institute; 1998.
24. Interian A, Martinez IE, Guarnaccia PJ, Vega WA, Escobar JI,. A Qualitative Analysis of the Perception of Stigma Among Latinos Receiving Antidepressants. Psychiatric Services December 2007; 58: 1591-1594.
25. Moyers TB, Martin T, Manuel JK, Hendrickson SM, Miller WR,. Assessing competence in the use of motivational interviewing. Journal of Substance Abuse Treatment 2005; 28: 19-26.
26. Beck AT, Steer RA, Brown GK,. Manual for Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996.
27. Penley JA, Wiebe JS, Nwosu A,. Psychometric Properties of the Spanish Beck Depression Inventory-II in a Medical Sample. Psychological Assessment 2003; 15: 569-577.
28. Wiebe JS, Penley JA,. A Psychometric Comparison of the Beck Depression Inventory-II in English and Spanish. Psychological Assessment 2005; 17: 481-485.
29. Morisky DE, Green LW, Levine DM,. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 1986; 24: 67-74.
30. George CF, Peveler RC, Heiliger S, Thompson C,. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000; 50: 166-171.
31. Interian A,. A Brief Self-Report Measure to Assess Antidepressant Adherence Among Spanish-Speaking Latinos. Journal of Clinical Psychopharmacology 2010; 30: 755-757.
32. Cohen J., Statistical Power Analysis for the Behavioral Sciences, Second Edition. Hillside, New Jersey: Lawrence Erlbaum Associates; 1988.
33. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X,. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008; 2.
34. Interian A, Lewis-Fernandez R, Dixon L,. Improving Treatment Engagement of Underserved U.S. Racial-Ethnic Groups: A Review of Recent Interventions Psychiatric Services 2012.
35. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653-661.
36. Trivedi MH, Morris DW, Pan J-Y, Grannemann BD, John Rush A,. What moderator characteristics are associated with better prognosis for depression? Neuropsychiatric Disease and Treatment 2005; 1: 51-57.
37. Miranda J, Azocar F, Organista KC, Dwyer E, Areane P,. Treatment of depression among impoverished primary care patients from ethnic minority groups. Psychiatric Services 2003; 54: 219-225.
38. Cooper-Patrick L, Crum RM, Ford DE,. Characteristics of patients with major depression who received care in general medical and specialty mental health settings. Medical Care 1994; 32: 15-24.
39. Klinkman MS, Schwenk TL, Coyne JC,. Depression in primary care-More like asthma than appendicitis: The Michigan Depression Project. The Canadian Journal of Psychiatry/La Revue canadienne de psychiatrie 1997; 42: 966-973.
40. Choo PW, Rand CS, Inui TS, et al. Validation of Patient Reports, Automated Pharmacy Records, and Pill Counts With Electronic Monitoring of Adherence to Antihypertensive Therapy. Medical Care 1999; 37: 846-857.
41. Byerly M, Thompson A, Carmody T, et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Services 2007; 58: 844-847.